International Assets Investment Management LLC Purchases 597,961 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

International Assets Investment Management LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 8,158.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 605,290 shares of the company's stock after purchasing an additional 597,961 shares during the quarter. International Assets Investment Management LLC owned about 0.13% of GE HealthCare Technologies worth $46,801,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Leavell Investment Management Inc. grew its holdings in shares of GE HealthCare Technologies by 6.2% during the 4th quarter. Leavell Investment Management Inc. now owns 25,819 shares of the company's stock worth $1,996,000 after purchasing an additional 1,500 shares during the period. Camelot Portfolios LLC acquired a new position in GE HealthCare Technologies during the 4th quarter worth about $336,000. Ballentine Partners LLC lifted its stake in GE HealthCare Technologies by 45.0% during the 4th quarter. Ballentine Partners LLC now owns 6,227 shares of the company's stock worth $481,000 after acquiring an additional 1,932 shares in the last quarter. Braun Stacey Associates Inc. lifted its stake in GE HealthCare Technologies by 3.6% during the 4th quarter. Braun Stacey Associates Inc. now owns 290,592 shares of the company's stock worth $22,469,000 after acquiring an additional 10,208 shares in the last quarter. Finally, DAVENPORT & Co LLC raised its position in GE HealthCare Technologies by 6.2% in the 4th quarter. DAVENPORT & Co LLC now owns 12,839 shares of the company's stock valued at $993,000 after purchasing an additional 748 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. HSBC assumed coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a "buy" rating and a $100.00 price target on the stock. Citigroup raised their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a "buy" rating in a research report on Wednesday, April 3rd. Argus raised their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. Morgan Stanley raised their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a research note on Monday, February 12th. Finally, Mizuho raised their price target on GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a "buy" rating in a research note on Wednesday, February 7th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.92.

GE HealthCare Technologies Stock Down 0.9 %

NASDAQ GEHC traded down $0.76 on Monday, hitting $87.71. 1,692,379 shares of the stock traded hands, compared to its average volume of 3,523,442. The stock has a 50-day moving average of $87.19 and a 200 day moving average of $76.78. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The company has a market capitalization of $40.02 billion, a P/E ratio of 29.04, a price-to-earnings-growth ratio of 3.08 and a beta of 0.95. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analysts' expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. GE HealthCare Technologies's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 earnings per share. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.97%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.